Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma-Reference-Cited by-同舟云学术

Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma

Published:2020-07-04 Issue:1 Volume:70 Page:31-45
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Chu Tan-Huy,Vo Manh-Cuong,Park Hye-Seong,Lakshmi Thangaraj Jaya,Jung Sung-Hoon,Kim Hyeoung-Joon,Lee Je-Jung^ORCID

Funder

National Research Foundation of Korea

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-020-02654-0.pdf

Reference52 articles.

1. Jung SH, Lee HJ, Vo MC, Kim HJ, Lee JJ (2017) Immunotherapy for the treatment of multiple myeloma. Crit Rev Oncol Hematol 111:87–93

2. Görgün GT, Whitehill G, Anderson JL, Hideshima T, Maguire C, Laubach J et al (2013) Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans. Blood 121(15):2975–2987

3. Kane RC, Farrell AT, Sridhara R, Pazdur R (2006) United States food and drug administration approval summary: bortezomib for the treatment of progressive multiple myeloma after one prior therapy. Clin Cancer Res 12(10):2955–2960

4. Kumar SK, Gertz MA (2014) Risk adapted therapy for multiple myeloma: back to basics. Leuk Lymphoma 55(10):2219–2220

5. Rosenblatt J, Avigan D (2008) Cellular immunotherapy for multiple myeloma. Best Pract Res Clin Haematol 21(3):559–577

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reprogramming the tumor immune microenvironment using engineered dual-drug loaded Salmonella;Nature Communications;2024-08-06

2. Exploring cellular immunotherapy platforms in multiple myeloma;Heliyon;2024-03

3. Efficacy of natural killer cell therapy combined with chemoradiotherapy in murine models of head and neck squamous cell carcinoma;Cytotherapy;2023-12

4. Impaired function of dendritic cells within the tumor microenvironment;Frontiers in Immunology;2023-06-27

5. Therapeutic strategies to enhance immune response induced by multiple myeloma cells;Frontiers in Immunology;2023-05-18